Not available outside of the UK & Ireland.
Biochem/physiol Actions
κ/µ opioid receptor agonist.
Features and Benefits
This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This product has met the following criteria: